# RAJAF (Cordyceps Sunshine Biotech Holdings Co., Ltd.) - SEC EDGAR Financial Statements

> Cordyceps Sunshine Biotech Holdings Co., Ltd. reported $1.25M in revenue and a net loss of $155K for the fiscal year ended December 31, 2025 (down 0.6% year over year), with a 61.1% gross margin and a -11.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/RAJAF
- Markdown: https://convexityos.com/fundamentals/RAJAF.md
- SEC CIK: 0001885680
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 20, 2026, 05:30 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001885680&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $1.25M | -0.6% YoY |
| Operating Income | FY 2025 | -$141K | -11.3% margin |
| Net Income | FY 2025 | -$155K | -12.4% net margin |
| Diluted EPS | FY 2025 | $0.00 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2025 | $3.2K | Total debt: $13K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.25M | $1.25M | $883K | $53K | $879K |
| Cost of Revenue | $485K | $347K | $116K | $14K | $1.06M |
| **Gross Profit** | $761K | $906K | $766K | $40K | -$176K |
| Research & Development | -- | -- | -- | $118K | $25K |
| Selling, General & Admin | -- | -- | -- | $576K | $301K |
| Total Operating Expenses | $902K | $1.09M | $539K | $455K | $119K |
| **Operating Income** | -$141K | -$184K | $228K | -$415K | -$119K |
| **EBITDA** | $68K | $240K | $285K | -$391K | $30K |
| Interest Income | -- | -- | $7 | $10 | $7 |
| Interest Expense | -- | -- | $27K | $72K | $12K |
| Income Before Tax | -$155K | -$191K | $191K | -$415K | -$119K |
| Income Tax Expense | -- | $35K | $22K | $792 | $351 |
| **Net Income** | -$155K | -$226K | $752K | -$720K | -$491K |
| Basic EPS | $0.00 | $0.00 | $0.01 | -$0.01 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | $0.01 | -$0.01 | $0.00 |
| Basic Shares Outstanding | 111.1M | 111.1M | 111.1M | 104.4M | 100.0K |
| Diluted Shares Outstanding | 111.1M | 111.1M | 111.1M | 104.4M | 100.0K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.2K | $37K | $23K | $6.6K | $100K | $294 |
| **Cash & Short-Term Investments** | $3.2K | $37K | $23K | $6.6K | $100K | $294 |
| Accounts Receivable, Net | -- | $305 | -- | $150K | $358K | -- |
| Inventory | $674K | -- | -- | $314K | $480K | $685K |
| Other Current Assets | $100K | $58K | $2.4K | -- | -- | -- |
| **Total Current Assets** | $998K | $602K | $327K | $502K | $1.13M | $949K |
| Property, Plant & Equipment, Net | $3.63M | $3.91M | $2.81M | $76K | $1.71M | $1.71M |
| Other Non-Current Assets | $14K | $13K | $14K | -- | -- | -- |
| **Total Non-Current Assets** | $3.66M | $4.02M | $3.02M | $1.60M | $2.13M | $1.88M |
| **Total Assets** | $4.66M | $4.62M | $3.35M | $2.10M | $3.26M | $2.83M |
| Accounts Payable | $365K | $276K | $185K | $751K | $112K | $123 |
| Short-Term Debt | -- | -- | -- | $57K | -- | -- |
| Other Current Liabilities | $7.9K | $5.2K | -- | $1.38M | -- | -- |
| **Total Current Liabilities** | $5.19M | $4.99M | $2.97M | $2.52M | $2.92M | $2.41M |
| Long-Term Debt | -- | -- | $431K | $414K | -- | -- |
| **Total Non-Current Liabilities** | $0 | $13K | $537K | $535K | $617K | $425K |
| **Total Liabilities** | $5.19M | $5.00M | $3.50M | $3.06M | $3.54M | $2.84M |
| **Total Debt (incl. Leases)** | $13K | $100K | $628K | $649K | $270K | $16K |
| Common Stock | $11K | $11K | $11K | $11K | $10K | $10K |
| Retained Earnings | -$854K | -$699K | -$473K | -$1.22M | -$504K | -$13K |
| Accumulated Other Comp. Income | $87K | $91K | $89K | $41K | -$3.7K | $664 |
| **Total Stockholders' Equity** | -$535K | -$376K | -$152K | -$951K | -$276K | -$13K |
| Total Equity | -$535K | -$376K | -$152K | -$951K | -$276K | -$13K |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.2K | $37K | $23K | $6.6K | $100K | $294 |
| **Cash & Short-Term Investments** | $3.2K | $37K | $23K | $6.6K | $100K | $294 |
| Accounts Receivable, Net | -- | $305 | -- | $150K | $358K | -- |
| Inventory | $674K | -- | -- | $314K | $480K | $685K |
| Other Current Assets | $100K | $58K | $2.4K | -- | -- | -- |
| **Total Current Assets** | $998K | $602K | $327K | $502K | $1.13M | $949K |
| Property, Plant & Equipment, Net | $3.63M | $3.91M | $2.81M | $76K | $1.71M | $1.71M |
| Other Non-Current Assets | $14K | $13K | $14K | -- | -- | -- |
| **Total Non-Current Assets** | $3.66M | $4.02M | $3.02M | $1.60M | $2.13M | $1.88M |
| **Total Assets** | $4.66M | $4.62M | $3.35M | $2.10M | $3.26M | $2.83M |
| Accounts Payable | $365K | $276K | $185K | $751K | $112K | $123 |
| Short-Term Debt | -- | -- | -- | $57K | -- | -- |
| Other Current Liabilities | $7.9K | $5.2K | -- | $1.38M | -- | -- |
| **Total Current Liabilities** | $5.19M | $4.99M | $2.97M | $2.52M | $2.92M | $2.41M |
| Long-Term Debt | -- | -- | $431K | $414K | -- | -- |
| **Total Non-Current Liabilities** | $0 | $13K | $537K | $535K | $617K | $425K |
| **Total Liabilities** | $5.19M | $5.00M | $3.50M | $3.06M | $3.54M | $2.84M |
| **Total Debt (incl. Leases)** | $13K | $100K | $628K | $649K | $270K | $16K |
| Common Stock | $11K | $11K | $11K | $11K | $10K | $10K |
| Retained Earnings | -$854K | -$699K | -$473K | -$1.22M | -$504K | -$13K |
| Accumulated Other Comp. Income | $87K | $91K | $89K | $41K | -$3.7K | $664 |
| **Total Stockholders' Equity** | -$535K | -$376K | -$152K | -$951K | -$276K | -$13K |
| Total Equity | -$535K | -$376K | -$152K | -$951K | -$276K | -$13K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$155K | -$226K | $752K | -$720K | -$491K |
| Depreciation & Amortization | $209K | $424K | $57K | $24K | $149K |
| Change in Receivables | -- | -- | -- | $186K | -$354K |
| Change in Inventory | -$359K | -- | -$193K | $49K | -$167K |
| Change in Payables | $77K | $105K | $183K | -$122K | $106K |
| **Operating Cash Flow** | -$36K | $312K | $360K | -$321K | -$365K |
| Capital Expenditure | -- | -$349K | -$319K | -$475 | -$100K |
| **Free Cash Flow** | -- | -$37K | $40K | -$322K | -$465K |
| **Investing Cash Flow** | -- | -$306K | -$320K | -$475 | -$111K |
| Common Stock Issued | -- | -- | -- | -- | $232K |
| **Financing Cash Flow** | -- | -- | -$32K | $246K | $575K |
| **Net Change in Cash** | -$34K | $14K | $7.0K | -$84K | $99K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 61.1% | 72.3% | 86.8% | 74.2% | -20.0% |
| **Operating Margin** | -11.3% | -14.7% | 25.8% | -778.8% | -13.6% |
| **Net Profit Margin** | -12.4% | -18.1% | 85.2% | -1350.9% | -55.8% |
| Return on Assets (ROA) | -3.3% | -4.9% | 22.4% | -34.2% | -15.0% |
| Current Ratio | 0.19x | 0.12x | 0.11x | 0.20x | 0.39x |
| Quick Ratio | 0.06x | 0.01x | 0.01x | 0.07x | 0.22x |
| **Revenue Growth (YoY)** | -0.6% | +42.0% | +1555.7% | -93.9% | -- |
| Gross Profit Growth (YoY) | -16.1% | +18.3% | +1837.4% | -- | -- |
| Operating Income Growth (YoY) | -- | -180.7% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -130.1% | -- | -- | -- |
| EPS Growth (YoY) | -- | -100.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -111.5% | -13.3% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -192.5% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
